Interleukin 12 shows a better curative effect on lung cancer than paclitaxel and cisplatin doublet chemotherapy

BACKGROUND: Interleukin 12 (IL-12) is a cytokine that has been reported to exhibit potent tumoricidal effects in animal tumor models. A combined approach using Paclitaxel and platinum-based doublet chemotherapy is the most commonly used backbone regimen for treating lung cancer. Despite numerous stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yue, Ting, Zheng, Xiaodong, Dou, Yaling, Zheng, Xiaohu, Sun, Rui, Tian, Zhigang, Wei, Haiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994391/
https://www.ncbi.nlm.nih.gov/pubmed/27549240
http://dx.doi.org/10.1186/s12885-016-2701-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994391/
https://www.ncbi.nlm.nih.gov/pubmed/27549240
http://dx.doi.org/10.1186/s12885-016-2701-7

Ejemplares similares